Search results for "Cannabinoid"

showing 10 items of 323 documents

TRPV1 channels as putative targets in the cannabinoid-mediated synaptic activity of hippocampal neurons

Endocannabinoids (eCBs) play a critical part in pathophysiological conditions rooted on neuronal excitability such as epilepsy. eCBs seem to be involved in neuroprotection, putatively acting on the cannabinoid receptor type 1 (CB1r), but also on Transient Receptor Potential Vanilloid type 1 channels (TRPV1). Indeed, CB1r and TRPV1 are involved in the transduction of stimuli at synaptic level, though exact molecular mechanisms are far from being unveiled. Thus, we aimed to investigate the role of CB1r/TRPV1 interplay in the rat hippocampal neurotransmission by whole-cell patch clamp technique to evaluate excitatory bioelectric activity in the CA1. We pharmacologically manipulated this pathwa…

TRPV1mEPSCelectorphysiologyhippocampucannabinoidpatch-clampSettore BIO/09 - Fisiologia
researchProduct

ROLE OF NITRIC OXIDE/cGMP PATHWAY IN CANNABINOID MODULATION OF PAROXYSMAL PHENOMENA

TRPV1temporal lobe epilepsy modelnitric oxidehippocampus.cannabinoidelectrophysiologySettore BIO/09 - Fisiologiabehaviourcannabinoids; nitric oxide; TRPV1; temporal lobe epilepsy models; electrophysiology; behaviour; hippocampus.
researchProduct

Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons: distinctive sufficiency for hippocampus-dependent and amygdala-dependent syna…

2013

A major goal in current neuroscience is to understand the causal links connecting protein functions, neural activity, and behavior. The cannabinoid CB1 receptor is expressed in different neuronal subpopulations, and is engaged in fine-tuning excitatory and inhibitory neurotransmission. Studies using conditional knock-out mice revealed necessary roles of CB1 receptor expressed in dorsal telencephalic glutamatergic neurons in synaptic plasticity and behavior, but whether this expression is also sufficient for brain functions is still to be determined. We applied a genetic strategy to reconstitute full wild-type CB1 receptor functions exclusively in dorsal telencephalic glutamatergic neurons a…

TelencephalonCannabinoid receptorLightBlotting WesternHippocampusGlutamic AcidBiologyNeurotransmissionAnxietyReal-Time Polymerase Chain ReactionAmygdalaHippocampus03 medical and health sciencesGlutamatergicMice0302 clinical medicineReceptor Cannabinoid CB1medicineExcitatory Amino Acid AgonistsAnimalsFear conditioning030304 developmental biologyMice KnockoutNeurons0303 health sciencesKainic AcidNeuronal PlasticityBehavior AnimalGeneral NeuroscienceArticlesAmygdalaEndocannabinoid systemImmunohistochemistryElectrophysiological PhenomenaMice Inbred C57BLmedicine.anatomical_structurenervous systemSynaptic plasticitySynapsesRNAlipids (amino acids peptides and proteins)Neuroscience030217 neurology & neurosurgerypsychological phenomena and processesJournal of Neuroscience
researchProduct

Studying mitochondrial CB1 receptors: Yes we can

2014

Text miningCannabinoid receptorbusiness.industryCorrespondenceMEDLINEMedicineCell BiologyComputational biologybusinessReceptorMolecular BiologyMolecular Metabolism
researchProduct

Detectability of cannabinoids in the serum samples of cannabis users: Indicators of recent cannabis use? A follow‐up study

2021

Forensic toxicologists are frequently required to predict the time of last cannabis consumption. Several studies suggested the utility of minor cannabinoids as indicators of recent cannabis use. Because several factors influence blood cannabinoid concentrations, the interpretation of serum cannabinoid concentrations remains challenging. To assess the informative value of serum cannabinoid levels in cannabis users (in total N = 117 patients, including 56 patients who stated an exact time of last cannabis use within 24 h before blood sampling), the detectability of cannabinoids, namely delta-9-tetrahydrocannabinol (delta-9-THC), 11-hydroxy-delta-9-THC, 11-nor-9-carboxy-delta-9-THC, cannabichr…

Time FactorsCannabigerolmedicine.medical_treatmentPharmaceutical SciencePhysiologyTetrahydrocannabivarin01 natural sciencesAnalytical Chemistry03 medical and health scienceschemistry.chemical_compoundCannabichromene0302 clinical medicineTandem Mass SpectrometrymedicineHumansEnvironmental Chemistry030216 legal & forensic medicineSpectroscopybiologyCannabinoidsbusiness.industry010401 analytical chemistrybiology.organism_classification0104 chemical sciencesSubstance Abuse DetectionchemistryTetrahydrocannabinolic acidCannabinolMarijuana UseCannabinoidSample collectionCannabisbusinessChromatography LiquidFollow-Up Studiesmedicine.drugDrug Testing and Analysis
researchProduct

Comparing illicit drug use in 19 European cities through sewage analysis

2012

Abstract: The analysis of sewage for urinary biomarkers of illicit drugs is a promising and complementary approach for estimating the use of these substances in the general population. For the first time, this approach was simultaneously applied in 19 European cities, making it possible to directly compare illicit drug loads in Europe over a 1-week period. An inter-laboratory comparison study was performed to evaluate the analytical performance of the participating laboratories. Raw 24-hour composite sewage samples were collected from 19 European cities during a single week in March 2011 and analyzed for the urinary biomarkers of cocaine, amphetamine, ecstasy, methamphetamine and cannabis u…

Time FactorsEcstasysewage biomarker analysis ; cocaine ; methamphetamine ; amphetamine ; MDMA ; CannabisSewageWaste Disposal FluidMethamphetamineCocaineTandem Mass SpectrometryAigües residualsPer capitaWaste Management and Disposaleducation.field_of_studybiologySewageSewage biomarker analysisMDMAPollutionEuropeChemistryGeographyPopulation Surveillancemedicine.drugEnvironmental MonitoringEnvironmental EngineeringMDMASubstance-Related DisordersPopulationEnvironmental healthmedicineEnvironmental ChemistryIllicit drugHumansCitieseducationBiologyCannabisbusiness.industryCannabinoidsIllicit DrugsAmphetaminesEnvironmental engineeringbiology.organism_classificationAmphetamineCannabisDroguesbusinessBiomarkersWater Pollutants ChemicalWaste disposalChromatography LiquidThe science of the total environment
researchProduct

Cannabinoid ligands sorting out by a 3D-QSAR approach using catalyst/hypogen

2009

National audience; Understanding how molecular structures are involved in recognition by a biological receptor is a decisive step in drug design, and could constitute an intricate problem because of existence of several binding sites, as is the case of GPCRs (1) that constitute the largest class of membrane receptors. In this context, identification of pharmacophores that should differentiate multiple binding modes is of particular interest. We have recently applied to ligands of a human olfactory receptor an original sorting-out procedure carried out using Catalyst/HypoGen software (Accelrys Ltd) (2). We aimed to validate this sorting out procedure using literature data, and in this way, w…

[SDV] Life Sciences [q-bio]CANNABINOID LIGANDS[SDV]Life Sciences [q-bio]CATALYST/HYPOGEN3D-QSAR APPROACH
researchProduct

COINVOLGIMENTO DELLO STRESS DEL RETICOLO E DEL PROCESSO AUTOFAGICO NELL’APOPTOSI INDOTTA DAL CANNABINOIDE SINTETICO WIN IN CELLULE DI EPATOMA UMANO I…

2009

Studi da noi condotti precedentemente hanno dimostrato la capacità del cannabinoide sintetico WIN di indurre apoptosi in cellule di epatocarcinoma umano HepG2 attraverso un meccanismo, dipendente dal fattore trascrizionale PPARg, che prevede riduzione dei livelli di alcuni fattori di sopravvivenza e attivazione di fattori pro-apoptotici della famiglia Bcl-2 (M. Giuliano et al. Biochimie. 2009). Recentemente è, inoltre, emerso che in cellule di glioma i cannabinoidi possono stimolare l’apoptosi attraverso induzione di stress del reticolo endoplasmatico seguito da autofagia. Scopo L'obiettivo del presente studio è stato quello di valutare il coinvolgimento dell’autofagia nel percorso di morte…

autophagy cannabinoids hepatoma cellsSettore BIO/10 - Biochimica
researchProduct

Mechanisms of endothelial cell activation by endocannabinoid 2-arachidonoylglycerol

2020

Abstract Background Endothelial dysfunction promotes atherogenesis, vascular inflammation, and thrombus formation. Reendothelialization after angioplasty is required in order to restore vascular function and to prevent stent thrombosis. The endocannabinoid (eCB) 2-arachidonoylglycerol (2-AG) is a known modulator of inflammation. Earlier studies have demonstrated the relevance of this endocannabinoid in human pathophysiology during coronary artery disease and in murine experimental atherogenesis. However, evidence on the impact of 2-AG on endothelial cell function remains scarce. Methods Endothelial repair was studied in two treatment groups of wildtype mice following electrical denudation o…

biologyEndotheliumCell adhesion moleculebusiness.industry2-Arachidonoylglycerolmedicine.diseaseEndocannabinoid systemCell biologyMonoacylglycerol lipaseEndothelial stem cellchemistry.chemical_compoundmedicine.anatomical_structurechemistryE-selectinmedicinebiology.proteinEndothelial dysfunctionCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

Modulators of Endogenous Neuroprotection: Estrogen, Corticotropin-releasing Hormone and Endocannabinoids

2005

Age-associated neurodegenerative disorders are among the most challenging problems of our aging society. Alzheimer’s disease is affecting people with increasing frequency, since there is a clear relationship between the incidence of this detrimental disorder and age. Other neurodegenerative disorders, including Parkinson’s disease, stroke and amyotrophic lateral sclerosis, are also frequently observed in our aging society. For most of these diseases, no causal therapy has yet been identified. Many of the treatments given to patients that are affected by these disorders have different side effects, and therefore the search is on to identify novel molecular approaches that may lead to a more …

business.industrymedicine.drug_classCentral nervous systemEstrogen receptorDiseaseNeuroprotectionEndocannabinoid systemCorticotropin-releasing hormonemedicine.anatomical_structureEstrogenmedicinebusinessCAMP response element bindingNeuroscience
researchProduct